[1]
T, P., PT, M. and E, A. 2021. IN SILICO DESIGN OF QUINOXALINE BEARING THIAZOLIDINONE DERIVATIVES AS PPARγ AGONIST IN DIABETES MELLITUS. Asian Journal of Pharmaceutical and Clinical Research. 14, 2 (Feb. 2021), 47–50. DOI:https://doi.org/10.22159/ajpcr.2021.v14i2.39838.